Tags

Type your tag names separated by a space and hit enter

Tobacco Product Use Among Adults - United States, 2019.
MMWR Morb Mortal Wkly Rep. 2020 Nov 20; 69(46):1736-1742.MM

Abstract

Cigarette smoking remains the leading cause of preventable disease and death in the United States (1). The prevalence of current cigarette smoking among U.S. adults has declined over the past several decades, with a prevalence of 13.7% in 2018 (2). However, a variety of combustible, noncombustible, and electronic tobacco products are available in the United States (1,3). To assess recent national estimates of tobacco product use among U.S. adults aged ≥18 years, CDC analyzed data from the 2019 National Health Interview Survey (NHIS). In 2019, an estimated 50.6 million U.S. adults (20.8%) reported currently using any tobacco product, including cigarettes (14.0%), e-cigarettes (4.5%), cigars (3.6%), smokeless tobacco (2.4%), and pipes* (1.0%).† Most current tobacco product users (80.5%) reported using combustible products (cigarettes, cigars, or pipes), and 18.6% reported using two or more tobacco products.§ The prevalence of any current tobacco product use was higher among males; adults aged ≤65 years; non-Hispanic American Indian/Alaska Native (AI/AN) adults; those whose highest level of educational attainment was a General Educational Development (GED) certificate; those with an annual household income <$35,000; lesbian, gay, or bisexual (LGB) adults; uninsured adults and those with Medicaid; those with a disability; or those with mild, moderate, or severe generalized anxiety disorder. E-cigarette use was highest among adults aged 18-24 years (9.3%), with over half (56.0%) of these young adults reporting that they had never smoked cigarettes. Implementing comprehensive, evidence-based, population level interventions (e.g., tobacco price increases, comprehensive smoke-free policies, high-impact antitobacco media campaigns, and barrier-free cessation coverage), in coordination with regulation of the manufacturing, marketing, and sale of all tobacco products, can reduce tobacco-related disease and death in the United States (1,4). As part of a comprehensive approach, targeted interventions are also warranted to reach subpopulations with the highest prevalence of use, which might vary by tobacco product type.

Authors+Show Affiliations

Office on Smoking and Health, National Center for Chronic Disease Prevention and Health Promotion, CDC.Office on Smoking and Health, National Center for Chronic Disease Prevention and Health Promotion, CDC.Office on Smoking and Health, National Center for Chronic Disease Prevention and Health Promotion, CDC.Office on Smoking and Health, National Center for Chronic Disease Prevention and Health Promotion, CDC.Office on Smoking and Health, National Center for Chronic Disease Prevention and Health Promotion, CDC.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

33211681

Citation

Cornelius, Monica E., et al. "Tobacco Product Use Among Adults - United States, 2019." MMWR. Morbidity and Mortality Weekly Report, vol. 69, no. 46, 2020, pp. 1736-1742.
Cornelius ME, Wang TW, Jamal A, et al. Tobacco Product Use Among Adults - United States, 2019. MMWR Morb Mortal Wkly Rep. 2020;69(46):1736-1742.
Cornelius, M. E., Wang, T. W., Jamal, A., Loretan, C. G., & Neff, L. J. (2020). Tobacco Product Use Among Adults - United States, 2019. MMWR. Morbidity and Mortality Weekly Report, 69(46), 1736-1742. https://doi.org/10.15585/mmwr.mm6946a4
Cornelius ME, et al. Tobacco Product Use Among Adults - United States, 2019. MMWR Morb Mortal Wkly Rep. 2020 Nov 20;69(46):1736-1742. PubMed PMID: 33211681.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Tobacco Product Use Among Adults - United States, 2019. AU - Cornelius,Monica E, AU - Wang,Teresa W, AU - Jamal,Ahmed, AU - Loretan,Caitlin G, AU - Neff,Linda J, Y1 - 2020/11/20/ PY - 2020/11/19/entrez PY - 2020/11/20/pubmed PY - 2020/11/21/medline SP - 1736 EP - 1742 JF - MMWR. Morbidity and mortality weekly report JO - MMWR Morb Mortal Wkly Rep VL - 69 IS - 46 N2 - Cigarette smoking remains the leading cause of preventable disease and death in the United States (1). The prevalence of current cigarette smoking among U.S. adults has declined over the past several decades, with a prevalence of 13.7% in 2018 (2). However, a variety of combustible, noncombustible, and electronic tobacco products are available in the United States (1,3). To assess recent national estimates of tobacco product use among U.S. adults aged ≥18 years, CDC analyzed data from the 2019 National Health Interview Survey (NHIS). In 2019, an estimated 50.6 million U.S. adults (20.8%) reported currently using any tobacco product, including cigarettes (14.0%), e-cigarettes (4.5%), cigars (3.6%), smokeless tobacco (2.4%), and pipes* (1.0%).† Most current tobacco product users (80.5%) reported using combustible products (cigarettes, cigars, or pipes), and 18.6% reported using two or more tobacco products.§ The prevalence of any current tobacco product use was higher among males; adults aged ≤65 years; non-Hispanic American Indian/Alaska Native (AI/AN) adults; those whose highest level of educational attainment was a General Educational Development (GED) certificate; those with an annual household income <$35,000; lesbian, gay, or bisexual (LGB) adults; uninsured adults and those with Medicaid; those with a disability; or those with mild, moderate, or severe generalized anxiety disorder. E-cigarette use was highest among adults aged 18-24 years (9.3%), with over half (56.0%) of these young adults reporting that they had never smoked cigarettes. Implementing comprehensive, evidence-based, population level interventions (e.g., tobacco price increases, comprehensive smoke-free policies, high-impact antitobacco media campaigns, and barrier-free cessation coverage), in coordination with regulation of the manufacturing, marketing, and sale of all tobacco products, can reduce tobacco-related disease and death in the United States (1,4). As part of a comprehensive approach, targeted interventions are also warranted to reach subpopulations with the highest prevalence of use, which might vary by tobacco product type. SN - 1545-861X UR - https://www.unboundmedicine.com/medline/citation/33211681/Tobacco_Product_Use_Among_Adults___United_States_2019_ L2 - https://doi.org/10.15585/mmwr.mm6946a4 DB - PRIME DP - Unbound Medicine ER -